Latest posts
-
Tesamorelin: Research on the GHRH Analogue and Its Documented Applications in Clinical Science

Tesamorelin is a synthetic GHRH analogue with FDA approval for HIV-associated lipodystrophy — one of the few growth hormone-related peptides to complete full clinical development. This research overview covers its mechanism, regulatory history, pivotal trial data, and emerging research in metabolic and cognitive applications.
-
MOTS-c: The Mitochondrial Peptide Reshaping Research on Cellular Energy and Metabolic Regulation

MOTS-c is a 16-amino acid peptide encoded by the mitochondrial genome, making it one of the only known mitochondrial-derived peptides to function as a systemic metabolic regulator. This research overview covers its discovery, proposed mechanisms involving AMPK activation, preclinical metabolic findings, and emerging human data.
-
hGH Fragment 176-191: Examining the Research on Growth Hormone’s Lipolytic Domain

Fragment 176-191 of human growth hormone is a 16-amino acid peptide studied for its proposed role in fat metabolism. This research overview examines the structural basis for research interest in this fragment, its proposed mechanisms, preclinical findings, and its relationship to the related compound AOD-9604.
-
AOD-9604: Research on the Growth Hormone Fragment and Its Role in Metabolic Science

AOD-9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, originally developed as a research tool for studying metabolic effects independent of hGH’s growth-promoting properties. This article reviews its structural origins, proposed mechanisms, preclinical findings, and clinical development history.
-
Retatrutide: A Research Overview of the Triple Receptor Agonist and What Early Clinical Data Suggests

Retatrutide is an investigational triagonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. This research overview examines the published pharmacology, preclinical data, and early-phase clinical trial findings that have made it one of the most closely watched compounds in metabolic peptide research.
-
Tirzepatide vs Semaglutide: What Does the Published Research Actually Show?

Tirzepatide vs Semaglutide: What Does the Published Research Actually Show? Introduction: Why the Incretin Class Has Reshaped Metabolic Research For decades, incretin biology sat at the margins of metabolic science — a well-characterized but therapeutically underleveraged axis. That changed when researchers began developing synthetic analogues capable of exploiting the glucagon-like peptide-1 (GLP-1) receptor’s role in…
-
Semaglutide GLP-1 Receptor Agonist: A Research Deep Dive into the Most Studied Incretin Peptide of the Last Decade

Semaglutide GLP-1 Receptor Agonist: A Research Deep Dive into the Most Studied Incretin Peptide of the Last Decade Few peptide compounds have generated as concentrated a body of peer-reviewed literature as semaglutide. Since its characterization as a long-acting GLP-1 receptor agonist, researchers have explored its effects across metabolic, cardiovascular, and — more recently — central…
-
BPC-157 Peptide Research: A Deep Dive into Mechanisms, Preclinical Findings, and the Science Behind Body Protection Compound

BPC-157 Peptide Research: A Deep Dive into Mechanisms, Preclinical Findings, and the Science Behind Body Protection Compound What if one of the most extensively studied repair peptides in preclinical literature wasn’t synthesized in a pharmaceutical lab — but isolated from the proteins naturally present in human gastric juice? That’s the origin story of BPC-157, a…
-
Cognitive Peptides: Semax, Selank, and the Neuropeptide Research Landscape

Semax, Selank, and DSIP represent three distinct neuropeptide research profiles — BDNF modulation, GABAergic anxiolysis, and sleep architecture — developed over decades of Russian and international research. This overview examines mechanisms, research limitations, and methodological considerations. For research use only.
-
Growth Secretagogues: What Researchers Are Studying in the GH Axis

Growth hormone secretagogues work upstream of GH itself, stimulating the pituitary to release GH within natural pulsatile rhythms. This research overview covers CJC-1295, Ipamorelin, Tesamorelin, and IGF-1 LR3 — their mechanisms, research profiles, and how they differ. For research use only.










